Humana Faces Sharp Decline In Medicare Star Ratings For 2025, Braces For 2026 Revenue Hit
Portfolio Pulse from Vandana Singh
Humana Inc. faces a significant decline in its Medicare Advantage Star Ratings for 2025, with only 25% of members in plans rated four stars and above, down from 94% in 2024. This drop, primarily due to contract H5216, will impact quality bonus payments in 2026. Humana is appealing the ratings and working to improve its performance.

October 02, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Humana's Medicare Advantage Star Ratings have dropped significantly for 2025, affecting future quality bonus payments and potentially impacting 2026 revenue. The company is appealing the ratings and working on improvements.
The sharp decline in Humana's Medicare Advantage Star Ratings from 94% to 25% for plans rated four stars and above is a significant issue. This drop is primarily due to contract H5216, which affects a large portion of Humana's membership. The lower ratings will impact quality bonus payments in 2026, leading to potential revenue loss. Humana is appealing the ratings and working on improvements, but the immediate impact is negative, as reflected in the 20.10% drop in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100